≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Small cell lung cancer

DOID Endpoint Browser

C3_SCLC

non-small cell lung carcinoma: A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

  • HLP_C3_SCLC
1134

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Cause of death: ICD-10 — C34
  • Cause of death: ICD-9 — 162
  • Cause of death: ICD-8 — 162
  • Cancer registry: Topography ICD-O-3 — C34
  • Cancer registry: Morphology ICD-O-3 — 8041
  • Cancer registry: Behaviour codes — 3

2 out of 7 registries used, show all original rules.

1134

4. Check minimum number of events

None

1134

5. Include endpoints

1134

6. Filter based on genotype QC (FinnGen only)

1098

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE
Control conditions
not HLP_C3_SCLC

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF8

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1098 270 828
Unadjusted period prevalence (%) 0.31 0.10 0.38
Median age at first event (years) 70.99 69.12 71.61

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1134
Matched controls
11340
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L01CB01
ATC
etoposide; systemic
+∞
307.7
314
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
16.8
307.7
456
437
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
307.7
337
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
307.7
697
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
12.0
307.7
459
606
A04AA01
ATC
ondansetron; systemic, rectal
49.0
307.7
293
80
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
307.7
310
*
A03FA01
ATC
metoclopramide; systemic, rectal
19.1
307.7
604
638
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
647
*
H02AB02
ATC
dexamethasone; systemic
161.5
307.7
489
53
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
58.1
307.7
278
63
Z51.5
ICD-10 Finland
Palliative care
14.3
303.2
314
296
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
+∞
287.0
263
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2786.4
253.9
236
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
248.3
229
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2576.2
238.1
222
*
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
+∞
217.9
202
*
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
+∞
210.1
195
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
191.2
178
*
XX3DW
NOMESCO Finland
Time consuming IT work
12.5
188.0
200
191
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
169.1
158
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
27.6
159.1
110
44
N02AA05
ATC
oxycodone; systemic
5.5
158.2
415
1071
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
1757.0
158.2
150
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
154.8
145
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
391.2
141.2
139
*
A04AA02
ATC
granisetron; systemic, transdermal
743.7
136.7
132
*
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
+∞
135.2
127
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
134.1
126
*
WF002
NOMESCO Finland
Radical radiotherapy
250.8
132.0
133
6
C34.96
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma
+∞
130.8
123
*
L03AA13
ATC
pegfilgrastim; parenteral
667.8
123.8
120
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
123.2
116
*
JN4AD
NOMESCO Finland
Body CT examination
7.1
121.5
203
336
JN4BD
NOMESCO Finland
Extensive body CT
8.2
112.8
161
223
C34.06
ICD-10 Finland
Malignant tumor of the main bronchial microcellular carcinoma
+∞
110.2
104
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.4
97.5
122
143
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
998.7
95.4
92
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
986.9
94.3
91
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
94.1
89
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
51.5
93.4
54
11
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
93.0
88
*
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
+∞
93.0
88
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
93.0
88
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
89.8
85
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
17.5
79.4
66
40
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
75.9
72
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
70.6
67
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
12.1
70.4
72
63
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
66.3
63
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
104.9
63.6
69
7
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
62.0
59
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
61.0
58
*
8041/3-C34.0
ICD-O-3
Small cell carcinoma, NOS, of main bronchus
+∞
61.0
58
*
TGD00
NOMESCO Finland
Needle biopsy of lung
214.7
59.7
61
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
18.1
57.8
47
27
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
57.8
55
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
158.2
57.5
60
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
149.9
54.4
57
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.9
53.6
333
1419
R84
ICPC
Malignant neoplasm bronchus/lung
284.1
53.6
54
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
53.6
51
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
542.3
52.9
52
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
14.3
52.2
48
35
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
+∞
51.4
49
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.5
51.1
105
208
N02AA01
ATC
morphine; systemic, rectal
8.5
50.8
67
83
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
266.9
50.5
51
*
C34.26
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung microcellular carcinoma
+∞
50.4
48
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
96.3
50.3
55
6
WW500
NOMESCO Finland
Blood transfusion
8.1
50.2
69
90
C61
ICD-10 Finland
Malignant neoplasm of prostate
177.8
49.3
51
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.8
49.2
339
1517
GD1AD
NOMESCO Finland
Thorax CT examination
4.8
48.7
116
261
L03AA02
ATC
filgrastim; parenteral
250.3
47.4
48
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
47.2
45
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
130.6
47.2
50
*
8041/3-C34.2
ICD-O-3
Small cell carcinoma, NOS, of middle lobe, lung
+∞
46.2
44
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
45.1
43
*
A06AH03
ATC
naloxegol; oral
18.6
44.8
36
20
A98
ICPC
Health maint/preventive medicine
0.4
42.6
529
7616
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
38.8
37
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
37.7
36
*
1623B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA MICROCELLURE]
+∞
37.7
36
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
63.8
37.4
43
7
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
379.3
37.2
37
*
N07BA03
ATC
varenicline; oral
5.5
35.5
70
133
JN4CD
NOMESCO Finland
Very extensive body CT
9.1
34.7
43
49
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
34.6
33
*
A04AD12
ATC
aprepitant; systemic
+∞
32.4
31
*
WW200, ,
SPAT
0.2
31.9
47
2044
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
169.8
31.9
33
*
116
Kela drug reimbursment
Prostate cancer
+∞
31.4
30
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
31.4
30
*
L01XX17
ATC
[U] topotecan
+∞
31.4
30
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
29.3
28
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
28.2
27
*
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.6
28.1
54
100
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
+∞
27.2
26
*
Z51.0
ICD-10 Finland
Radiotherapy session
277.4
26.8
27
*
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
74.5
25.9
29
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.8
25.1
80
223
L01CE01
ATC
topotecan; systemic
+∞
25.1
24
*
H02AB06
ATC
prednisolone; systemic
1.9
24.7
551
3754
1625B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA MICROCELLURE]
+∞
24.0
23
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
24.0
23
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
24.0
23
*
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
127.7
23.7
25
*
WZC30
NOMESCO Finland
Teaching
2.6
23.5
152
640
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
23.0
22
*
115
Kela drug reimbursment
Breast cancer
+∞
23.0
22
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
23.0
22
*
R03BB04
ATC
tiotropium bromide; inhalant
2.3
22.9
212
1049
N40
ICD-10 Finland
Hyperplasia of prostate
0.4
22.6
145
2979
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
5.6
22.6
43
79
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.2
21.6
40
1552
A79
ICPC
Malignancy NOS
117.3
21.6
23
*
N06DA02
ATC
donepezil; oral
0.1
21.1
7
718
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.4
21.1
164
751
Z72.0
ICD-10 Finland
Tobacco use
5.5
21.0
41
77
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
+∞
20.9
20
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
20.9
20
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
20.9
20
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
19.8
19
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
19.8
19
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
203.4
19.6
20
*
I10
ICD-10 Finland
Essential (primary) hypertension
0.6
19.6
448
6115
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
35.0
18.9
24
7
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
18.8
18
*
N06DX01
ATC
memantine; oral
0.1
18.7
11
974
ZX120
NOMESCO Finland
Intravenous
2.7
18.7
103
399
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.1
18.6
83
286
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
6.1
18.3
32
54
NK6AN
NOMESCO Finland
Total body bone isotope imaging
53.4
18.0
21
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
53.4
18.0
21
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
53.4
18.0
21
*
L02AE02
ATC
leuprorelin; implant, parenteral
67.7
17.8
20
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
17.8
17
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
17.6
82
290
EB4VA, ,
NOMESCO Finland
0.1
17.3
6
599
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
+∞
16.7
16
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
28.0
16.5
22
8
SFA20
NOMESCO Finland
Two-surface restoration
0.5
16.4
203
3382
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
16.4
441
3070
R04.2
ICD-10 Finland
Haemoptysis
3.1
16.3
70
236
P20
ICPC
Memory disturbance
0.3
16.3
48
1448
G04CA02
ATC
tamsulosin; oral
0.5
16.1
188
3196
SAA02
NOMESCO Finland
Basic examination of mouth
0.5
16.0
247
3855
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
15.7
15
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
15.7
15
*
TQW40, ,
SPAT
0.1
14.9
*
461
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
14.6
14
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
14.6
14
*
1628B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA MICROCELLURE]
+∞
14.6
14
*
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
+∞
14.6
14
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.9
14.5
32
67
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
15.6
14.4
23
15
C10AA05
ATC
atorvastatin; oral
0.6
14.2
256
3863
M79.6
ICD-10 Finland
Pain in limb
0.5
14.1
162
2791
J01MA12
ATC
levofloxacin; systemic
1.8
14.0
227
1356
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
16.0
14.0
22
14
1240
FHL
Bronchoscopy
4.4
13.9
35
82
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.1
13.9
29
58
OAB44, ,
SPAT
0.1
13.8
5
480
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
20.3
13.8
20
10
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
13.8
314
4463
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
13.7
13
805
SFA10
NOMESCO Finland
One-surface restoration
0.5
13.7
201
3220
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
13.7
494
3662
SFA30
NOMESCO Finland
Three-surface restoration
0.5
13.6
141
2518
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.6
13
*
L02BB03
ATC
bicalutamide; oral
+∞
13.6
13
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
13.6
13
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
13.6
13
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
141.6
13.5
14
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
141.6
13.5
14
*
M25.5
ICD-10 Finland
Pain in joint
0.4
13.5
80
1754
H25.1
ICD-10 Finland
Senile nuclear cataract
0.5
13.3
186
3028
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.4
13.1
94
1918
J01MA14
ATC
moxifloxacin; systemic
2.2
13.1
114
545
C10AA07
ATC
rosuvastatin; oral
0.5
13.1
133
2394
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.5
13.0
175
2885
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.6
12.9
238
3594
I87.1
ICD-10 Finland
Compression of vein
50.6
12.9
15
*
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
+∞
12.5
12
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
12.5
12
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
12.5
12
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
20.3
12.5
18
9
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
5.1
12.5
26
52
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
12.4
87
378
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.3
12.2
42
1180
N03AX14
ATC
levetiracetam; systemic
3.5
12.2
42
124
GEA00
NOMESCO Finland
Mediastinoscopy
18.3
12.1
18
10
EB1VA, ,
NOMESCO Finland
0.2
12.0
20
845
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.4
11.9
87
1769
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
11.9
152
2560
M01AH05
ATC
etoricoxib; oral
0.6
11.8
270
3880
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.0
11.7
53
185
L02BG04
ATC
letrozole; oral
65.6
11.6
13
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
11.5
11
*
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
+∞
11.5
11
*
A04AA03
ATC
tropisetron; systemic
+∞
11.5
11
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
11.5
11
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
+∞
11.5
11
*
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.5
11.4
139
2381
N02BE01
ATC
paracetamol; systemic, rectal
0.6
11.3
638
7545
JN6AD
NOMESCO Finland
CT of torso and neck
11.3
11.1
20
18
ZX050
NOMESCO Finland
Stereotactic radiotherapy
43.8
10.9
13
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.0
10.9
116
599
G04CB02
ATC
dutasteride; oral
0.3
10.8
25
871
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.4
10.8
65
1429
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
10.8
72
1519
L17
ICPC
Foot/toe symptom/complaint
0.5
10.8
109
1984
G04CB01
ATC
finasteride; oral
0.5
10.7
82
1644
R4110, ,
SPAT
0.2
10.7
20
787
R85
ICPC
Malignant neopl respiratory other
60.6
10.6
12
*
L08
ICPC
Shoulder symptom/complaint
0.4
10.6
61
1364
D19
ICPC
Teeth/gum symptom/complaint
0.4
10.6
70
1482
Z01.2
ICD-10 Finland
Dental examination
0.5
10.5
146
2414
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
+∞
10.4
10
*
1622B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA MICROCELLURE]
+∞
10.4
10
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
10.4
10
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
+∞
10.4
10
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
10.4
10
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
10.4
10
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
10.4
10
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
10.4
10
*
SDA02
NOMESCO Finland
Periodontal treatment, brief
0.5
10.4
101
1866
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.7
10.3
32
88
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
10.7
10.3
19
18
K02.1
ICD-10 Finland
Caries of dentine
0.6
10.3
237
3431
WZC00, ,
SPAT
0.3
10.2
22
797
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.3
10.1
38
1027
L15
ICPC
Knee symptom/complaint
0.5
10.0
73
1494
H02
ICPC
Hearing complaint
0.4
9.9
49
1171
SDA03
NOMESCO Finland
Periodontal treatment
0.5
9.9
119
2056
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
0.6
9.9
213
3140
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
0.6
9.8
224
3259
KCD02
NOMESCO Finland
Transurethral resection of bladder
10.7
9.8
18
17
OAB42, ,
SPAT
0.2
9.8
18
716
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
9.8
64
1363
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.4
9.7
65
1374
K03.64
ICD-10 Finland
Dental calculus supragingival
0.4
9.7
67
1399
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.1
9.6
40
133
J01FA06
ATC
roxithromycin; oral
1.5
9.5
388
2896
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
100.9
9.4
10
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
100.9
9.4
10
*
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
100.9
9.4
10
*
WPB10
NOMESCO Finland
Making a convalescent care decision
17.7
9.4
14
8
WF099
NOMESCO Finland
Other radiotherapy
30.3
9.4
12
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
9.4
9
*
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
+∞
9.4
9
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
9.4
9
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
9.4
9
*
1624B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA MICROCELLURE]
+∞
9.4
9
*
YX9AW, ,
NOMESCO Finland
+∞
9.4
9
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
9.4
9
*
TGA30
NOMESCO Finland
Thoracocentesis
7.0
9.3
22
32
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.1
9.3
5
362
HA1AA
NOMESCO Finland
X-ray mammography
3.5
9.2
31
90
L12
ICPC
Hand/finger symptom/complaint
0.3
9.2
34
928
G30.8
ICD-10 Finland
Other Alzheimer disease
0.1
9.1
*
312
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.2
9.0
14
621
HAB40
NOMESCO Finland
Wedge excision of mammary gland
15.7
9.0
14
9
Z71.8
ICD-10 Finland
Other specified counselling
0.5
9.0
104
1824
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
18.8
8.9
13
7
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.7
8.9
49
190
SPAT1312
SPAT
General health counselling
0.5
8.9
110
1892
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.6
8.9
229
3256
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
6.9
8.9
21
31
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.7
8.8
27
74
N05CF01
ATC
zopiclone; oral
1.5
8.7
365
2727
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.2
8.7
23
56
N02AX02
ATC
tramadol; systemic, rectal
1.5
8.7
417
3202
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.3
8.7
24
760
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.5
8.6
83
1547
C10AX09
ATC
ezetimibe; oral
0.4
8.6
59
1237
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
16.4
8.6
13
8
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
90.7
8.4
9
*
GDC00
NOMESCO Finland
Lobectomy of lung
90.7
8.4
9
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
8.3
8
*
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
+∞
8.3
8
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
8.3
8
*
GD004
NOMESCO Finland
Palliative radiotherapy of trachea, bronchi and lungs
+∞
8.3
8
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
8.3
8
*
D82
ICPC
Teeth/gum disease
0.5
8.3
111
1872
Z01.7
ICD-10 Finland
Laboratory examination
0.4
8.3
35
897
B01AF02
ATC
apixaban; oral
0.4
8.3
51
1115
B02AA02
ATC
tranexamic acid; systemic
1.9
8.3
103
562
SPAT1053
SPAT
Memory test
0.5
8.2
70
1358
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.4
8.1
44
1011
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.7
8.0
25
69
G04BD12
ATC
mirabegron; oral
0.3
8.0
27
771
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.3
8.0
60
270
SPAT1325
SPAT
Vaccination
0.6
8.0
169
2527
M05BX04
ATC
denosumab; parenteral
2.5
7.9
50
208
S18
ICPC
Laceration/cut
0.6
7.8
232
3221
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.6
7.8
152
2323
XX1AD
NOMESCO Finland
Other CT-examination
45.3
7.7
9
*
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
45.3
7.7
9
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.6
7.7
227
3158
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.4
7.7
36
884
N05AX08
ATC
risperidone; systemic
0.4
7.7
32
828
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
7.5
7.7
17
23
H13
ICPC
Plugged feeling ear
0.5
7.7
83
1493
L13
ICPC
Hip symptom/complaint
0.5
7.6
63
1238
L28
ICPC
Limited function/disability (L)
0.5
7.6
94
1623
A97
ICPC
No disease
0.5
7.6
61
1210
A07AA02
ATC
nystatin; oral
2.2
7.6
61
283
WZC30, ,
SPAT
0.2
7.5
12
521
G04CA01
ATC
alfuzosin; oral
0.5
7.5
68
1294
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.6
7.5
204
2887
HAC20
NOMESCO Finland
Total mastectomy
80.6
7.4
8
*
J01DB01
ATC
cefalexin; oral
0.7
7.4
552
6486
H91.1
ICD-10 Finland
Presbycusis
0.3
7.4
18
608
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
7.4
136
836
N17
ICPC
Vertigo/dizziness
0.4
7.3
33
823
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
7.3
7
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
7.3
7
*
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
+∞
7.3
7
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
7.3
7
*
1629X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,EI HIST/SYTOL DG]
+∞
7.3
7
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
7.3
7
*
C34.14
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary macrocellular anaplastic carcinoma
+∞
7.3
7
*
5826
FHL
Lobectomy or bilobectomy
+∞
7.3
7
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
7.3
7
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
15.9
7.2
11
7
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
4.3
7.2
18
42
TGC00
NOMESCO Finland
Bronchial lavation
2.9
7.2
32
111
N06DA03
ATC
rivastigmine; oral, transdermal
0.2
7.2
11
491
L82
ICD-10 Finland
Seborrhoeic keratosis
0.5
7.2
50
1045
P70
ICPC
Dementia
0.1
7.2
*
235
SCA01
NOMESCO Finland
Preventive oral health care, short
0.5
7.1
71
1313
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
7.1
133
2058
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.7
7.1
224
3082
I50.0
ICD-10 Finland
Congestive heart failure
0.5
7.1
51
1054
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
7.0
11
484
C09AA05
ATC
ramipril; oral
0.6
7.0
182
2608
F01.9
ICD-10 Finland
Vascular dementia, unspecified
0.0
6.9
*
205
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
6.9
74
383
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
13.9
6.9
11
8
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
13.9
6.9
11
8
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.6
6.9
100
1653
R42
ICD-10 Finland
Dizziness and giddiness
0.6
6.8
116
1841
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.4
6.8
13
14
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.3
6.8
22
639
C09CA01
ATC
losartan; oral
0.6
6.8
134
2046
KMAK, ,
NOMESCO Finland
0.7
6.7
201
2804
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.5
6.7
39
157
A69.2
ICD-10 Finland
Lyme disease
0.2
6.6
6
306
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.4
6.6
35
814
A02BA02
ATC
ranitidine; systemic
1.5
6.6
229
1637
D01BA02
ATC
terbinafine; oral
0.6
6.6
112
1776
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
8.8
6.6
13
15
M01AX05
ATC
glucosamine; oral
0.6
6.6
85
1452
C08CA01
ATC
amlodipine; oral
0.7
6.5
264
3474
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.6
6.5
123
1902
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.5
6.5
78
1363
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
6.2
6.5
16
26
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.6
6.5
132
2004
K85
ICPC
Elevated blood pressure
0.5
6.5
65
1199
I50.9
ICD-10 Finland
Heart failure, unspecified
0.6
6.4
130
1979
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.5
6.4
45
940
K05.31
ICD-10 Finland
Periodontitis pronounced
1.7
6.4
106
631
L02BA01
ATC
tamoxifen; oral
70.2
6.4
7
*
UGC02
NOMESCO Finland
Rigid bronchoscopy
70.2
6.4
7
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.2
6.4
9
358
C09CA06
ATC
candesartan; oral
0.6
6.4
93
1537
K80
ICPC
Cardiac arrhythmia NOS
0.3
6.3
15
512
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
0.3
6.3
21
600
8041/3-C34.8
ICD-O-3
Small cell carcinoma, NOS, of overlapping lesion of lung
+∞
6.3
6
*
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
+∞
6.3
6
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
6.3
6
*
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
+∞
6.3
6
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
+∞
6.3
6
*
OAA41
NOMESCO Finland
Health check based on individual needs
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
6.3
6
*
C34.34
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or hunga macrocellular anaplastic carcinoma
+∞
6.3
6
*
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
6.3
6
*
1629B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA MICROCELLURE]
+∞
6.3
6
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
6.3
6
*
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
+∞
6.3
6
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
6.3
6
*
ZYC01, ,
SPAT
0.3
6.2
15
510
XG410
NOMESCO Finland
Flow-volume spirometry
2.3
6.2
47
213
A06AC01
ATC
ispaghula (psylla seeds); oral
0.6
6.2
126
1917
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
0.4
6.2
26
668
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
6.1
89
1474
U02
ICPC
Urinary frequency/urgency
0.4
6.1
35
789
SPAT1043
SPAT
Audiometry
0.4
6.1
29
706

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 500 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Proper column names.
  • Show details (e.g. Fisher or Chi-square test, N cases and N controls) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV not working.
  • No filters and sorters.
  • Limited amount of endpoints with TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP Concept
ln(OR) -5y
ln(OR) -1y
ln(OR) -1m
ln(OR) d0
ln(OR) +1m
ln(OR) +1y
ln(OR) +5y
MCC -5y
MCC -1y
MCC -1m
MCC d0
MCC +1m
MCC +1y
MCC +5y
Malignant tumour
130 (2001600128)
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
C34.16 (2000500605)
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
C34.36 (2000500623)
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
C34.86 (2000500632)
Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma
C34.96 (2000500641)
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
C50.41 (2000501002)
Palliative radiotherapy
WF004 (2001310703)
Metastasis
OMOP4998856 (36769180)
Secondary malignant neoplasm of other specified sites
C79.8 (45547524)
Malignant tumor of the main bronchial microcellular carcinoma
C34.06 (2000500596)
Malignant tumor of the upper lobe, bronchus or lung without histology
C34.10 (2000500599)
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
C34.19 (2000500607)
Malignant tumor of the lower lobe, bronchus or lung without histology
C34.30 (2000500617)
Malignant overall tumor of bronchus and lung without histology
C34.80 (2000500626)
Malignant tumor in unspecified location in bronchus and lung without histology
C34.90 (2000500635)
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
C34.99 (2000500643)
Biopsy of the lung with CT guidance
GD1CT (2001303738)
Radiotherapy of metastasis
WF049 (2001310705)
Metastasis to intrahepatic bile ducts
OMOP5031661 (35226180)
Metastasis to liver
OMOP5000224 (36770544)
Lymph node Pathology biopsy report
66112-4 (40768795)
Malignant neoplasm: Overlapping lesion of bronchus and lung
C34.8 (45542590)
Malignant neoplasm of prostate
C61 (45547509)
Malignant neoplasm of bronchus and lung
C34 (45595645)
Malignant neoplasm: Upper lobe, bronchus or lung
C34.1 (45595646)
Secondary malignant neoplasm of liver and intrahepatic bile duct
C78.7 (45595688)
Malignant tumor of the main bronchus without histology
C34.00 (2000500590)
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
C34.12 (2000500601)
Malignant tumor of the middle lobe, bronchus or lung microcellular carcinoma
C34.26 (2000500614)
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
C34.39 (2000500625)
Flexible bronchoscopy with biopsy of lung
UGC18 (2001303611)
Thorax extensive CT-examination
GD1BD (2001303621)
CT examination of thorax for dose design of radiotherapy
YG1AD (2001303663)
Needle biopsy of lung
TGD00 (2001303750)
Bronchoscopic ultrasonography
XGX32 (2001303818)
Multiple adjuvant cytostatic therapy
WB113 (2001310629)
Demanding cystostatic therapy of methastized malignancy
WD125 (2001310680)
Extensive body CT
JN4BD (2001310899)
granisetron; oral, parenteral, transdermal
A04AA02 (21600494)
etoposide
L01CB01 (21603718)
pegfilgrastim; parenteral
L03AA13 (21603856)
Erythrocytes [#/volume] in Pleural fluid
26456-4 (3028308)
Enolase.neuron specific [Mass/volume] in Serum or Plasma
15060-7 (3028531)
Mycobacterium sp identified in Specimen
40699-1 (3042631)
Cytology report of Tissue fine needle aspirate Cyto stain
33718-8 (3043109)
Metastasis to cerebrum
OMOP5031569 (35226101)
Immunohistochemistry procedure
117617002 (4035726)
Pleura Pathology biopsy report
66123-1 (40768806)
Malignant neoplasm: Overlapping lesion of bladder
C67.8 (45532924)
Malignant neoplasm: Bronchus or lung, unspecified
C34.9 (45542592)
Pleural effusion, not elsewhere classified
J90 (45605897)
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA MICROCELLURE]
1623B (2000401270)
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA MICROCELLURE]
1625B (2000401286)
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
C34.15 (2000500604)
Extensive CT of head and brain
AA1BD (2001300110)
Puncture of pleura with ultrasound guidance
GA4YT (2001303531)
Thorax and upper abdomen combined extensive CT examination of
GD5BD (2001303656)
Extensive CT examination of thorax for dose design of radiotherapy
YG1BD (2001303664)
Very extensive CT examination of thorax for dose design of radiotherapy
YG1CD (2001303665)
Biopsy of the lung with ultrasound guidance
GD1AT (2001303736)
Needle biopsy of mediastinum
TGE00 (2001303807)
Biopsy of liver with ultrasound guidance
JJ2AT (2001305254)
Biopsy of lymphnode with ultrasound guidance
PJ2AT (2001309679)
Demanding neoadjuvant cytostatic therapy
WB121 (2001310630)
Cystostatic therapy of methastized malignancy
WD105 (2001310678)
Multiple cystostatic therapy of methastized malignancy
WD115 (2001310679)
Very extensive body CT
JN4CD (2001310902)
Other CT eamination for dose design of radiotherapy
YX9AD (2001311065)
Radiotherapy with large shaped fields - isocentric therapy
ZX012 (2001311468)
Intensity modified radiotherapy
ZX070 (2001311478)
Other technic of radiotherapy
ZX090 (2001311480)
Malignant neoplasm bronchus/lung
R84 (2002000952)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 (2002330110)
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: Unspecified
SMOKING-1-1-0 (2002330116)
aprepitant; oral, parenteral
A04AD12 (21600505)
leuprorelin; implant, parenteral
L02AE02 (21603825)
filgrastim; parenteral
L03AA02 (21603851)
Protein [Mass/volume] in Pleural fluid
2882-9 (3003434)
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 (3005702)
Carcinoembryonic Ag [Mass/volume] in Pleural fluid
19169-2 (3009804)
Microscopic observation [Identifier] in Buccal smear by Cyto stain
18501-7 (3018559)
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 (3023081)
Leukocytes [#/volume] in Pleural fluid
26467-1 (3023199)
Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
35704-6 (3036428)
Cell count panel - Pleural fluid
34561-1 (3045788)
Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
47826-3 (3052649)
Metastasis to bone marrow
OMOP5031538 (35226074)
Spread to lymph node
OMOP4998263 (36768587)
Metastasis to bone
OMOP4998978 (36769301)
Oncology Clinic/Center
261QX0200X (38004268)
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
60022-1 (40763082)
Body height measure
50373000 (4177340)
Body mass index
60621009 (4245997)
Adenocarcinoma, NOS, of prostate gland
8140/3-C61.9 (44499685)
Small cell carcinoma, NOS, of lung, NOS
8041/3-C34.9 (44500542)
Localized enlarged lymph nodes
R59.0 (45534459)
Malignant neoplasm: Main bronchus
C34.0 (45552250)
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
C77.1 (45557012)
Secondary malignant neoplasm of bone and bone marrow
C79.5 (45571540)
Neoplasm of uncertain or unknown behaviour: Mediastinum
D38.3 (45571613)
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
D38.6 (45571614)
Tobacco use
Z72.0 (45581063)
Chemotherapy session for neoplasm
Z51.1 (45595526)
Malignant neoplasm: Middle lobe, bronchus or lung
C34.2 (45595647)
Malignant neoplasm: Lower lobe, bronchus or lung
C34.3 (45605263)
palonosetron, combinations
A04AA55 (45893275)
Bronchoscopy
1240 (2000100109)
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
C34.11 (2000500600)
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
C34.35 (2000500622)
Malignant overall tumor of the bronchus and lung other or unspecified histology
C34.89 (2000500634)
Extensive MRI examination of brain with high intensity magnet
AA1CG (2001300116)
CT examination of head and neck for dose design of radiotherapy
YA1AD (2001300718)
Extensive CT examination of head and neck for dose design of radiotherapy
YA1BD (2001300719)
CT examination of arteria pulmonalis
FB1AD (2001302404)
Ultrasound examination of thorax
GA1AE (2001303415)
Intercostal insertion of pleural drainage tube
GAA10 (2001303430)
Thorax CT examination
GD1AD (2001303618)
X-ray examination of the lungs in one projection
GD1PA (2001303645)
Thorax X-ray examination outside radiological department
GD1UA (2001303652)
Thorax and upper abdomen combined CT examination of
GD5AD (2001303655)
Ultrasound examination of upper part of abdomen
JN1AE (2001305517)
Simple adjuvant cytostatic therapy
WB103 (2001310627)
Multiple neoadjuvant cytostatic therapy
WB111 (2001310628)
Adjuvant radiotherapy
WF003 (2001310702)
Profylactic radiotherapy
WF090 (2001310706)
Noninvasive ventilation
WX725 (2001310828)
Monitored bed care
WX892 (2001310850)
Teaching
WZC30 (2001310891)
Body CT examination
JN4AD (2001310897)
Other extensive CT eamination for dose design of radiotherapy
YX9BD (2001311066)
Image guided radiotherapy
ZX080 (2001311479)
Combined chemoradiotherapy
ZX095 (2001311481)
Social worker
Z2446 (2001311559)
Prostate cancer
116 (2001600116)
Dalteparin and tinzaparin (treatment for more than 6 months)
166 (2001600165)
Cough
R05 (2002000886)
ondansetron; oral, parenteral, rectal
A04AA01 (21600493)
tropisetron; oral, parenteral
A04AA03 (21600495)
calcium (different salts in combination); oral
A12AA20 (21600872)
salmeterol and fluticasone
R03AK06 (21603280)
allopurinol; oral, parenteral
M04AA01 (21604131)
morphine; oral, parenteral, rectal
N02AA01 (21604256)
oxycodone; oral, parenteral
N02AA05 (21604260)
fentanyl; nasal, sublingual, transdermal
N02AB03 (21604272)
Hemoglobin [Mass/volume] in Arterial blood
30313-1 (3002173)
Sodium [Moles/volume] in Urine
2955-3 (3003181)
Base excess in Arterial blood by calculation
1925-7 (3003396)
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 (3003785)
Band form neutrophils/Leukocytes in Blood
26508-2 (3004809)
Bicarbonate [Moles/volume] in Arterial blood
1960-4 (3008152)
Differential panel - Pleural fluid
29583-2 (3012441)
Bicarbonate [Moles/volume] in Capillary blood
1961-2 (3015235)
Calcium [Moles/volume] in Serum or Plasma
2000-8 (3015377)
Oxygen saturation in Arterial blood
2708-6 (3016502)
aPTT in Platelet poor plasma by Coagulation assay
14979-9 (3018677)
Gas panel - Arterial blood
24336-0 (3019060)
pH of Arterial blood
2744-1 (3019977)
Protein [Mass/volume] in Serum or Plasma
2885-2 (3020630)
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 (3021337)
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 (3022250)
Oxygen [Partial pressure] in Arterial blood
2703-7 (3027801)
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 (3027946)
Oxygen [Partial pressure] in Capillary blood
2704-5 (3028626)
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 (3029187)
Prothrombin time (PT) actual/Normal
5894-1 (3033658)
Cancer Ag 125 [Units/volume] in Serum or Plasma
10334-1 (3037551)
Bacteria identified in Isolate by Culture
43409-2 (3042936)
Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32785-8 (3043405)
Metastasis to cerebellum
OMOP5031566 (35226098)
Metastasis to cerebral meninges
OMOP5031567 (35226099)
Clinic/Center
261Q00000X (38004207)
Neurology
13 (38004458)
Medical Oncology
90 (38004507)
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 (4010399)
Short blood count panel - Blood
55429-5 (40758558)
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 (40762366)
Liver Pathology biopsy report
65752-8 (40768441)
Tissue Pathology biopsy report
66121-5 (40768804)
Diffusion capacity of lung
54715006 (4182985)
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 (42529201)
lipegfilgrastim; parenteral
L03AA14 (43534819)
Small cell carcinoma, NOS, of lower lobe, lung
8041/3-C34.3 (44499678)
Small cell carcinoma, NOS, of middle lobe, lung
8041/3-C34.2 (44500000)
Small cell carcinoma, NOS, of main bronchus
8041/3-C34.0 (44502159)
Small cell carcinoma, NOS, of upper lobe, lung
8041/3-C34.1 (44502427)
Upper gastrointestinal surgery
106 (44777669)
Occupatioal Medicine
901 (44777713)
Hypo-osmolality and hyponatraemia
E87.1 (45542779)
Palliative care
Z51.5 (45547323)
Chronic obstructive pulmonary disease, unspecified
J44.9 (45548115)
Abnormal findings on diagnostic imaging of lung
R91 (45548995)
Other interstitial pulmonary diseases with fibrosis
J84.1 (45557630)
Haemoptysis
R04.2 (45577777)
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
D38.1 (45605357)
Radiotherapy session
Z51.0 (45609946)
topotecan
L01CE01 (947868)
metoclopramide; oral, parenteral, rectal
A03FA01 (21600484)
Pulmonary Disease
29 (38004472)
dexamethasone; oral, parenteral
H02AB02 (21602730)
Magnesium [Moles/volume] in Serum or Plasma
2601-3 (3012095)
olodaterol and tiotropium bromide
R03AL06 (1588644)
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 (3006140)
FEV1/FVC
19926-5 (3011505)
Forced vital capacity [Volume] Respiratory system
19870-5 (3020158)
FEV1
20150-9 (3024653)
Inpatient Hospital
21 (8717)
Thorax X-ray examination
GD1AA (2001303617)
Supplier / Service Provider
OMOP5117446 (33004)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
Outpatient Hospital
22 (8756)
Emergency Room Visit
ER (9203)
Treatment plan or consultation
WZC00 (2001310885)
Cortisol [Moles/volume] in Serum or Plasma
14675-3 (3036481)
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 (3020059)
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 (3044938)
Other specified chronic obstructive pulmonary disease
J44.8 (45586673)
Neutrophils [#/volume] in Blood by Automated count
751-8 (3013650)
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 (3043924)
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 (3038288)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 (3048816)
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 (3035995)
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 (3006923)
pH of Serum or Plasma
2753-2 (3018418)
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 (3023024)
pH of Capillary blood
2745-8 (3009343)
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 (43055554)
Emergency Medicine
93 (38004510)
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 (3021347)
Pneumonia, unspecified
J18.9 (45601123)
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 (3001668)
FEV1 --post bronchodilation
20155-8 (3023550)
FEV1/FVC --post bronchodilation
69970-2 (42868459)
FVC percent change Respiratory system
69982-7 (42868471)
FEV1 percent change
69983-5 (42868472)
Sodium [Moles/volume] in Serum or Plasma
2951-2 (3019550)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 (3016431)
Potassium [Moles/volume] in Serum or Plasma
2823-3 (3023103)
Internal Medicine
11 (38004456)
Chronic obstructive pulmonary disease with acute lower respiratory infection
J44.0 (45601131)
levofloxacin; inhalant, oral, parenteral
J01MA12 (21603019)
Bacteria identified in Blood by Culture
600-7 (3023368)
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 (40764999)
Emergency Room and Inpatient Visit
ERIP (262)
Creatinine [Moles/volume] in Serum or Plasma
14682-9 (3020564)
Metamyelocytes/Leukocytes in Blood
28541-1 (3002179)
INR in Blood by Coagulation assay
34714-6 (3032080)
Differential panel, method unspecified - Blood
69738-3 (42870588)
erdosteine; oral
R05CB15 (21603394)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
MCH [Entitic mass]
28539-5 (3035941)
Platelets [#/volume] in Blood
26515-7 (3007461)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
Bacterial pneumonia, unspecified
J15.9 (45557621)
Albumin [Mass/volume] in Serum or Plasma
1751-7 (3024561)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
Cathetrisation of vein
TPH04 (2001309597)
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 (3002385)
Gas panel - Capillary blood
24337-8 (3022313)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
Blasts/Leukocytes in Blood
26446-5 (3025159)
Myelocytes/Leukocytes in Blood
26498-6 (3017181)
CBC panel - Blood by Automated count
58410-2 (40761511)
Eosinophils/Leukocytes in Blood
26450-7 (3006504)
Basophils/Leukocytes in Blood
30180-4 (3022096)
Monocytes/Leukocytes in Blood
26485-3 (3019069)
General Practice
1 (38004446)
Inpatient Visit
IP (9201)
Fever, unspecified
R50.9 (45582716)
Lymphocytes/Leukocytes in Blood
26478-8 (3002030)
Promyelocytes/Leukocytes in Blood
26524-9 (3021440)
pH of Specimen
17433-4 (3019225)
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 (3004490)
Pulmonary embolism without mention of acute cor pulmonale
I26.9 (45552785)
Neutrophils/Leukocytes in Blood
26511-6 (3018010)
ECG with 12 standard connections
XF400 (2001303368)
Monocytes [#/volume] in Blood
26484-6 (3001604)
Basophils [#/volume] in Blood
26444-0 (3006315)
Laboratory Visit
OMOP4822461 (32036)
Lymphocytes [#/volume] in Blood
26474-7 (3019198)
Eosinophils [#/volume] in Blood
26449-9 (3013115)
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 (3003338)
Outpatient Visit
OP (9202)
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 (3019902)
ethylmorphine; oral
R05DA01 (21603397)
Dyspnoea
R06.0 (45558449)
Microorganisms panel - Urine sediment
58435-9 (40761536)
Chloride [Moles/volume] in Serum or Plasma
2075-0 (3014576)
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 (3013721)
Office Visit
OMOP4822458 (581477)
prednisolone; oral, parenteral
H02AB06 (21602734)
prednisolone
A07EA01 (21600653)
Malaise and fatigue
R53 (45553741)
Flexible bronchoscopy
UGC12 (2001303610)
fenoterol and ipratropium bromide
R03AL01 (43534843)
Normoblasts [#/volume] in Blood
715-3 (3021589)
Oxygen [Partial pressure] in Venous blood
2705-2 (3024354)
Supine thorax X-ray examination
GD1QA (2001303648)
tiotropium bromide; inhalant
R03BB04 (21603296)
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 (21602863)
ABO and Rh group [Type] in Blood
882-1 (3003694)
enoxaparin; parenteral
B01AB05 (21600976)
Blood type and Crossmatch panel - Blood
34531-4 (3044640)
CBC W Ordered Manual Differential panel - Blood
57782-5 (40760892)
Type 2 diabetes mellitus, without complications
E11.9 (45561952)
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 (46236098)
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 (3016771)
Physiotherapy
R4110 (2001310233)
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 (3019800)
tinzaparin; parenteral
B01AB10 (21600981)
nystatin; oral
A07AA02 (21600604)
oxycodone and naloxone; oral
N02AA55 (21604265)
Atrial fibrillation and flutter
I48 (45596206)
Osmolality of Urine
2695-5 (3026782)
Medical doctor
Z2221 (2001311556)
roxithromycin; oral
J01FA06 (21602974)
Carbon dioxide [Partial pressure] in Venous blood
2021-4 (3021447)
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 (3026910)
Blood group antibody screen [Presence] in Serum or Plasma
890-4 (3001079)
Epithelial cells [#/volume] in Urine
30383-4 (3000850)
Abdominal CT examination
JN3AD (2001305554)
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 (3014162)
Essential (primary) hypertension
I10 (45591453)
Shortness of breath/dyspnoea
R02 (2002000883)
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 (586526)
oxazepam; oral
N05BA04 (21604569)
Bacteria [Presence] in Urine
87829-8 (36304419)
Phosphate [Moles/volume] in Serum or Plasma
14879-1 (3003458)
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 (3051714)
Base excess in Venous blood by calculation
1927-3 (3002032)
Erythrocytes [#/volume] in Urine
30391-7 (3002582)
moxifloxacin; oral, parenteral
J01MA14 (21603021)
Casts [#/volume] in Urine by Automated count
51483-6 (3030467)
Gas panel - Venous blood
24339-4 (3000991)
pH of Venous blood
2746-6 (3012544)
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 (3029287)
Anaemia, unspecified
D64.9 (45600610)
codeine; oral
R05DA04 (21603399)
salbutamol; inhalant
R03AC02 (21603256)
amoxicillin; oral, parenteral
J01CA04 (21602823)
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 (3007220)
Leukocytes [#/volume] in Urine
30405-5 (3018095)
doxycycline; oral, parenteral
J01AA02 (21602800)
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 (40765161)
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 (3042194)
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 (3011960)
magnesium hydroxide; oral
A02AA04 (21600052)
magnesium hydroxide; oral
G04BX01 (21602658)
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 (3030306)
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 (706163)
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA (2001301913)
Intravenous
ZX120 (2001311495)
Case Management Agency
251B00000X (38004193)
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 (3040853)
Bacteria [#/volume] in Urine by Automated count
51480-2 (3031040)
tramadol; oral, parenteral, rectal
N02AX02 (21604298)
Atherosclerotic heart disease
I25.1 (45596196)
Atherosclerosis of arteries of extremities
I70.2 (45538421)
Aid fitting and borrowing and monitoring of use
SPAT1230 (2001700331)
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 (3029879)
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 (2001304788)
Cough
R05 (45606792)
Dentistry
C5 (903277)
Bacteria identified in Urine by Culture
630-4 (3026008)
lactulose; oral
A06AD11 (21600571)
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
J44.1 (45601132)
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 (3016417)
varenicline; oral
N07BA03 (21604819)
EKG study
11524-6 (3013512)
loperamide; oral
A07DA03 (21600646)
loperamide oxide; oral
A07DA05 (21600648)
codeine and paracetamol
N02AJ06 (1123647)
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 (3013707)
pantoprazole; oral, parenteral
A02BC02 (21600097)
levetiracetam; oral, parenteral
N03AX14 (21604436)
paracetamol; oral, parenteral, rectal
N02BE01 (21604344)
Urate [Moles/volume] in Serum or Plasma
14933-6 (3026493)
12 lead EKG panel
34534-8 (3044889)
ranitidine; oral, parenteral
A02BA02 (21600083)
ranitidine bismuth citrate; oral
A02BA07 (21600088)
lorazepam; oral, parenteral, sublingual
N05BA06 (21604571)
Albumin [Presence] in Urine by Test strip
50949-7 (3029937)
Heart failure, unspecified
I50.9 (45576879)
Urinalysis macro (dipstick) panel - Urine
24357-6 (3037467)
ibuprofen
R02AX02 (1588667)
ibuprofen; oral, parenteral, rectal
M01AE01 (21603967)
zopiclone; oral
N05CF01 (21604654)
Otolaryngology
4 (38004449)
fluconazole; oral, parenteral
J02AC01 (21603080)
macrogol; oral
A06AD15 (21600575)
Erythrocytes [Presence] in Urine by Automated
53292-9 (3041096)
Ketones [Presence] in Urine by Test strip
2514-8 (3035350)
Nitrite [Presence] in Urine by Test strip
5802-4 (3021601)
potassium chloride; oral
A12BA01 (21600877)
Pharmacy visit
OMOP4822462 (581458)
Hemoglobin [Presence] in Urine by Test strip
5794-3 (3011397)
Glucose [Presence] in Urine by Test strip
25428-4 (3009261)
Extensive CT examination of arteria pulmonalis
FB1BD (2001302407)
pregabalin; oral
N02BF02 (955152)
pH of Urine
2756-5 (3015736)
ciprofloxacin; oral, parenteral
J01MA02 (21603009)
temazepam; oral
N05CD07 (21604642)
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 (3030366)
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 (40763086)
HIV 1 and 2 tests - Meaningful Use set
75622-1 (46235355)
Home Visit
OMOP4822459 (581476)
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 (3045783)
General Surgery
2 (38004447)
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 (3005785)
omeprazole; oral, parenteral
A02BC01 (21600096)
Chron obstructive pulmonary disease
R95 (2002000960)
Limited function/disability NOS
A28 (2002000162)
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 (36031861)
cefalexin; oral
J01DB01 (21602870)
Gas panel - Central venous blood
97535-9 (1616796)
Bacterial infection, unspecified
A49.9 (45590816)
Sampling
SPAT1263 (2001700364)
Standard MRI examination of brain with high intensity magnet
AA1BG (2001300112)
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 (3046279)
Ferritin [Mass/volume] in Serum or Plasma
2276-4 (3001122)
Basic examination of mouth
SAA02 (2001310275)
Thoracic and Cardiac Surgery
OMOP4822009 (45756830)
Oral Surgery
19 (38004464)
tranexamic acid; oral, parenteral
B02AA02 (21601036)
furosemide; oral, parenteral
C03CA01 (21601518)
denosumab; parenteral
M05BX04 (21604169)
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 (46235759)
sulfamethoxazole and trimethoprim
J01EE01 (21602961)
sucralfate; oral
A02BX02 (21600111)
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 (3044254)
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 (3008486)
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 (3018251)
Telephone prescription or other care instructions
WZB00 (2001310884)
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 (3051552)
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 (3009201)
Prostate specific Ag [Mass/volume] in Serum or Plasma
2857-1 (3013603)
Caries of dentine
K02.1 (45548134)
Cardiology
6 (38004451)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 (3004410)
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 (3001308)

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
291
183
21.05
307.65
1.3
1.2
—
—
—
0
0
264
416
7.97
167.77
2.1
1.4
32.34
2.91
ug/l
2.54
242
316
93
112
8.96
72.45
1.5
2.7
—
—
—
0
0
323
1263
3.18
61.67
4.3
2.3
0.77
0.83
mmol/l
11.94
313
1153
78
2928
0.21
44.94
1.7
2.0
1.60
1.29
mmol/l
1.09
65
2394
453
6971
0.42
44.10
6.3
7.4
41.81
40.89
mmol/mol
1.14
395
6401
487
7159
0.44
39.48
4.5
6.5
2.53
2.48
mmol/l
0.63
425
6529
462
6921
0.44
39.20
4.2
5.5
1.32
1.41
mmol/l
4.50
402
6281
469
6981
0.44
39.02
4.1
5.6
4.36
4.34
mmol/l
0.21
412
6393
447
6685
0.45
35.91
4.3
4.9
1.84
2.06
mu/l
2.65
391
5990
494
7115
0.46
35.64
4.7
5.7
6.37
6.14
mmol/l
2.48
427
6373
32
25
13.14
33.26
1.3
1.6
—
—
—
0
0
456
6646
0.48
31.91
3.8
4.7
1.44
1.27
mmol/l
4.47
396
5967
580
7744
0.49
30.63
40.6
25.0
124.92
134.25
g/l
40.05
572
7577
580
7742
0.49
30.56
40.3
24.8
4.13
4.42
e12/l
32.08
561
7457
580
7742
0.49
30.56
40.1
24.7
30.72
30.55
pg
1.45
572
7577
580
7742
0.49
30.56
40.7
25.3
37.63
39.97
%
26.10
571
7570
580
7741
0.49
30.53
40.4
24.9
255.29
234.94
e9/l
7.66
564
7492
580
7741
0.49
30.53
40.2
24.8
92.58
91.92
fl
2.64
572
7574
581
7745
0.49
30.36
40.3
24.9
7.94
6.95
e9/l
16.01
562
7462
581
7702
0.50
28.92
36.5
22.5
77.45
86.82
umol/l
7.47
570
7539
351
5416
0.49
26.43
3.6
3.9
15.48
15.08
pmol/l
1.62
302
4813
67
159
4.42
26.14
1.5
1.3
75.62
59.24
mmol/l
2.09
61
126
581
7612
0.51
26.06
32.6
21.3
4.02
4.03
mmol/l
0.27
569
7390
220
3990
0.44
25.92
1.9
2.3
88.10
92.87
pmol/l
0.78
124
2139
581
7603
0.52
25.78
32.8
21.2
137.10
139.76
mmol/l
35.30
570
7395
573
7502
0.52
24.92
17.8
10.6
28.05
25.09
u/l
2.06
561
7139
546
7251
0.52
24.80
24.4
15.6
—
—
—
0
0
223
3950
0.46
24.10
4.1
4.3
1.88
2.29
ug/l
1.87
193
3498
49
97
5.23
23.71
1.5
1.4
—
—
—
0
0
37
60
6.34
22.01
1.4
1.2
12.41
14.73
u/l
1.21
37
55
400
5723
0.53
21.64
36.0
22.0
331.25
331.75
g/l
0.50
393
5673
181
3358
0.45
21.47
1.8
2.3
71.11
78.15
nmol/l
2.91
157
2907
51
117
4.52
20.75
1.3
1.4
3545.11
1277.98
e6/l
1.36
45
82
376
2373
1.87
20.42
4.8
5.2
—
—
—
0
0
36
63
5.87
19.86
1.2
1.2
11.06
10.00
u/l
0.23
36
55
132
2655
0.43
18.79
1.6
1.8
17.36
19.55
nmol/l
0.97
120
2212
536
3837
1.75
18.67
9.6
3.8
10.84
12.69
umol/l
2.28
526
3604
45
104
4.46
18.15
1.3
1.4
24801.06
35473.98
e6/l
0.21
36
57
36
69
5.36
18.05
1.2
1.6
258.30
271.87
mosm/kgh2o
1.70
27
47
45
105
4.42
17.94
1.2
1.4
—
—
—
0
0
326
2039
1.84
17.79
2.2
1.7
—
—
—
0
0
385
2537
1.78
17.64
4.4
4.2
—
—
—
0
0
106
2250
0.42
16.98
2.6
3.0
0.79
0.77
ug/l
0.09
73
1584
175
3043
0.50
16.10
3.1
3.4
6.96
7.47
mmol/l
1.02
137
2542
24
13
18.83
16.04
1.0
1.0
—
—
—
0
0
529
3905
1.66
15.48
14.0
5.8
4.79
4.53
e9/l
1.38
482
3314
420
5638
0.59
15.31
35.4
20.4
14.74
13.81
%
28.22
415
5522
108
2198
0.44
15.31
3.4
3.8
—
—
—
0
0
198
3268
0.52
15.28
2.7
3.0
281.54
144.15
ug/l
5.50
182
2969
178
3009
0.52
14.70
3.0
3.5
74.19
49.80
mg/l
0.66
122
1982
185
3086
0.52
14.63
4.0
4.2
21.57
8.80
mg/mmol
1.01
117
1975
581
7168
0.61
14.53
29.7
16.9
32.38
27.74
mg/l
3.02
561
5979
271
3947
0.59
12.77
3.7
4.0
0.00
0.00
estimate
-0.00
81
829
277
4007
0.59
12.68
3.7
4.0
0.00
2.07
estimate
0.50
83
845
119
596
2.11
12.12
2.7
3.7
1.17
0.84
%
0.79
87
135
25
29
8.79
12.04
1.1
1.2
100.94
1.97
ug/l
—
20
10
283
4032
0.60
11.97
3.7
4.0
0.00
0.03
estimate
2.07
81
785
36
100
3.69
11.40
1.4
1.5
—
—
—
0
0
447
3339
1.56
11.38
5.7
5.5
8.86
9.15
%
1.07
441
3066
24
49
4.98
11.24
1.8
1.5
58.08
22.76
ng/l
1.38
24
49
34
93
3.74
11.01
1.4
1.8
73.93
29.04
u/ml
1.13
27
82
338
2383
1.60
10.97
5.1
3.2
7.40
7.40
ph
1.11
261
1735
438
3336
1.51
9.81
5.7
5.4
1.72
2.99
%
40.09
432
3064
220
3169
0.62
9.06
3.2
3.5
6.18
6.27
ph
0.62
126
1769
412
5200
0.67
9.02
4.0
4.5
—
2.94
—
0
7
107
574
1.95
9.01
2.7
3.5
0.82
0.67
%
0.33
79
135
106
578
1.92
8.51
2.7
3.7
0.23
0.05
%
0.87
75
119
209
3008
0.63
8.45
4.0
4.0
0.00
0.02
estimate
1.87
72
678
154
2344
0.60
7.79
2.5
2.3
3.27
2.85
mg/l
1.64
137
1980
85
444
1.99
7.74
4.8
3.6
—
—
—
0
0
114
1871
0.57
7.71
4.2
4.2
1.02
1.02
kg/l
0.40
90
1226
40
152
2.69
7.61
1.8
1.9
122.17
47.70
u/ml
0.37
35
116
45
182
2.53
7.57
4.0
4.6
2.82
2.57
mmol/l
0.26
34
116
457
3644
1.43
7.54
5.1
5.3
0.70
0.63
e9/l
4.50
407
3068
458
3661
1.42
7.42
5.1
5.3
0.04
0.04
e9/l
0.02
410
3086
112
653
1.79
7.29
4.5
3.6
5.37
5.16
kpa
1.50
106
616
461
3703
1.41
7.21
5.3
5.4
1.77
1.76
e9/l
0.02
415
3203
108
628
1.80
7.09
2.5
1.7
514.17
371.69
nmol/l
3.26
103
569
109
638
1.78
7.00
4.6
3.6
7.43
7.41
ph
1.50
99
530
464
3766
1.39
6.69
5.3
5.4
0.15
0.21
e9/l
12.40
414
3221
437
3518
1.39
6.59
6.0
3.7
32.03
34.86
g/l
17.76
413
3206
333
2582
1.41
6.17
5.6
2.0
2.37
2.34
mmol/l
3.15
311
2233
456
3728
1.37
6.14
7.2
5.4
1.21
1.20
mmol/l
0.52
445
3352
101
603
1.74
6.08
2.8
3.8
0.07
0.02
%
0.76
71
114
123
1869
0.62
6.01
1.7
1.8
1084.76
1138.03
nmol/l
0.28
97
1414
131
1955
0.63
5.91
1.7
1.8
434.10
24567449.76
pmol/l
1.46
109
1559
496
4132
1.36
5.84
7.5
5.7
1.21
1.21
mmol/l
0.59
426
3507
65
1131
0.55
5.32
1.3
1.3
23.86
11.78
u/ml
0.57
21
394
43
201
2.18
5.31
3.8
4.1
—
—
—
0
0
6
265
0.22
5.26
1.2
1.1
—
121.00
—
0
6
30
120
2.54
5.24
1.8
2.4
—
—
—
0
0
72
1184
0.58
4.80
1.3
1.3
121.17
39.65
iu/ml
1.17
25
353
219
1650
1.41
4.65
5.5
2.1
2.54
2.45
mmol/l
16.70
201
1442
14
401
0.34
4.26
2.0
2.0
—
—
—
0
0
92
1375
0.64
4.11
1.1
1.3
0.82
1.55
u/ml
1.63
18
366
14
35
4.04
4.10
3.6
3.3
0.86
1.06
index
0.55
14
35
176
2320
0.71
4.06
3.7
4.0
0.00
0.00
estimate
0.50
65
735
258
3198
0.75
3.97
2.8
3.3
1640.27
1889.61
ng/l
0.24
237
2782
224
2827
0.74
3.89
2.3
2.3
273.85
263.82
u/l
0.04
208
2640
90
600
1.54
3.58
4.0
4.3
—
—
—
0
0
154
2018
0.73
3.38
3.7
3.6
0.00
0.01
estimate
1.15
64
630
69
1044
0.64
3.27
1.4
1.2
—
—
—
0
0
35
184
1.93
3.27
2.0
2.5
33.03
33.63
umol/l
0.07
29
166
478
4195
1.24
3.16
12.4
19.9
1.23
1.41
inr
10.04
400
3539
105
747
1.45
3.08
2.0
1.6
65.25
66.35
g/l
0.86
95
664
205
1631
1.31
3.02
2.4
2.8
530.25
538.16
mosm/kgh2o
0.21
176
1422
167
2116
0.75
2.90
2.8
2.6
340.79
368.37
umol/l
1.77
145
1771
15
58
2.61
2.88
1.0
1.1
—
—
—
0
0
379
4336
0.81
2.80
5.1
3.1
103.83
51.53
u/l
5.06
351
3937
22
107
2.08
2.58
2.1
2.0
88.80
89.72
%
0.34
22
107
456
5093
0.82
2.58
4.2
4.7
35.33
3660.86
e6/l
—
9
109
21
405
0.51
2.50
1.2
1.4
—
60.99
—
0
26
208
2512
0.79
2.46
2.8
3.3
—
—
—
0
0
40
634
0.62
2.38
2.5
2.9
6.19
6.05
ph
0.40
32
466
87
1177
0.72
2.33
1.1
1.3
3.07
2.84
g/l
0.35
49
671
105
788
1.37
2.31
4.3
3.5
7.36
7.36
ph
0.10
98
516
12
274
0.43
2.30
10.2
11.4
—
—
—
0
0
23
418
0.54
2.29
2.5
2.4
—
—
—
0
0
7
19
3.70
2.15
1.6
1.5
1689.71
58.47
nmol/24h
—
7
19
31
509
0.60
2.15
1.7
2.2
11.41
15.28
nmol/l
2.59
24
453
0
57
0.00
2.05
0.0
1.2
—
—
—
0
0
5
148
0.33
2.00
2.0
1.8
183.80
209.28
pmol/l
—
5
139
5
11
4.56
1.94
1.0
1.0
—
—
—
0
0
143
1157
1.27
1.88
1.7
2.0
—
—
—
0
0
116
1452
0.78
1.84
2.1
2.5
11.29
12.15
umol/l
0.61
109
1320
5
12
4.18
1.82
1.0
1.2
34.00
18.00
u/l
—
5
6
20
108
1.87
1.82
3.4
2.6
5.40
4.73
e9/l
0.45
20
108
78
584
1.36
1.79
1.7
1.6
—
—
—
0
0
8
29
2.77
1.79
1.8
2.3
—
—
—
0
0
11
233
0.47
1.79
2.5
4.3
—
—
—
0
0
71
944
0.74
1.75
2.4
2.5
4.00
6.88
ug/l
3.18
60
815
135
1096
1.26
1.74
5.6
6.4
7.42
7.41
ph
0.22
87
648
108
1346
0.78
1.67
2.1
2.5
2.18
2.23
g/l
0.37
97
1222
6
19
3.17
1.66
4.0
1.9
0.59
0.61
mmol/l
—
6
19
10
209
0.47
1.59
1.4
1.3
—
—
—
0
0
134
1100
1.25
1.58
5.6
6.4
1.73
1.11
mmol/l
0.78
107
887
19
320
0.59
1.52
1.4
1.2
112.63
97.79
u/ml
—
6
118
70
905
0.76
1.45
1.2
1.3
378.95
559.45
titre
1.04
19
220
5
16
3.13
1.44
2.4
1.1
—
—
—
0
0
133
1106
1.23
1.41
5.6
6.4
5.10
5.07
kpa
0.09
122
1060
133
1106
1.23
1.41
5.6
6.4
10.22
11.10
kpa
1.57
122
1060
12
223
0.53
1.37
3.4
3.1
7.46
7.76
mmol/l
0.15
12
214
15
82
1.84
1.36
1.5
1.4
—
—
—
0
0
15
82
1.84
1.36
1.5
1.4
—
—
—
0
0
15
82
1.84
1.36
1.5
1.4
—
—
—
0
0
15
82
1.84
1.36
1.5
1.4
—
—
—
0
0
164
1399
1.20
1.36
4.0
4.1
—
—
—
0
0
0
37
0.00
1.34
0.0
1.4
—
5.33
—
0
6
74
578
1.30
1.33
4.1
3.9
—
—
—
0
0
11
54
2.05
1.33
1.3
1.2
—
—
—
0
0
0
40
0.00
1.32
0.0
1.3
—
156.60
—
0
40
326
3586
0.87
1.30
4.0
4.5
26.84
143.41
ng/l
1.61
285
2857
21
130
1.63
1.27
4.6
2.5
58.81
60.26
%
0.12
21
130
15
254
0.59
1.26
3.3
3.1
1.40
1.72
mmol/l
1.29
15
245
20
315
0.63
1.26
3.8
1.8
—
—
—
0
0
38
270
1.42
1.25
5.4
5.1
1.34
1.40
mmol/l
0.20
28
240
53
693
0.75
1.22
1.3
1.3
—
—
—
0
0
32
221
1.46
1.22
4.3
3.6
6.57
1.55
index
1.43
23
114
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
5
20
2.51
1.15
1.6
2.3
—
—
—
0
0
105
1244
0.83
1.07
2.3
2.6
20.94
21.91
%
0.30
98
1135
29
406
0.71
1.05
1.0
1.2
755.67
298.14
u/ml
0.48
24
375
129
1107
1.19
1.03
4.0
4.5
1.07
1.02
mmol/l
0.61
121
992
20
298
0.67
1.02
1.6
1.5
50.01
36.42
mg/l
0.57
14
250
20
298
0.67
1.02
1.6
1.5
59.38
52.82
mg/l
0.18
15
249
270
2962
0.88
1.01
3.5
3.9
35.14
129.60
e6/l
6.17
211
2168
95
795
1.21
1.00
3.3
2.2
12.50
8.49
umol/l
0.91
80
700
49
625
0.77
0.98
3.1
3.8
98.44
95.98
ng/l
0.05
42
527
0
30
0.00
0.97
0.0
1.1
—
1.51
—
0
15
0
31
0.00
0.96
0.0
1.2
—
28.20
—
0
26
0
31
0.00
0.96
0.0
1.2
—
138.65
—
0
26
234
2115
1.13
0.95
11.3
4.6
—
—
—
0
0
0
32
0.00
0.95
0.0
1.4
—
135.30
—
0
23
18
269
0.66
0.94
1.6
1.4
1.43
1.37
ratio
0.17
11
158
6
28
2.15
0.91
1.3
1.1
—
—
—
0
0
99
1154
0.84
0.87
2.7
2.0
2.05
1.74
%
1.75
90
1014
16
240
0.66
0.86
1.0
1.3
—
—
—
0
0
60
488
1.24
0.85
1.2
1.1
—
—
—
0
0
161
1804
0.87
0.84
3.6
4.5
166.73
431.65
ng/l
2.37
137
1568
6
111
0.54
0.83
3.0
2.5
1.21
1.18
mmol/l
—
6
111
6
114
0.52
0.83
3.0
2.5
104.67
105.56
mmol/l
—
6
114
6
114
0.52
0.83
3.0
2.5
4.13
4.09
mmol/l
—
6
114
73
870
0.83
0.82
2.8
2.0
80.00
65.74
e9/l
1.60
48
663
0
24
0.00
0.79
0.0
1.1
—
96.20
—
0
24
0
25
0.00
0.79
0.0
1.1
—
1797.80
—
0
25
77
650
1.20
0.78
2.3
2.2
38.84
34.66
u/l
0.25
67
513
0
27
0.00
0.77
0.0
1.3
—
23.00
—
0
18
0
28
0.00
0.76
0.0
1.1
—
3.11
—
0
12
36
459
0.78
0.76
1.1
1.3
—
—
—
0
0
36
458
0.78
0.75
1.1
1.2
—
—
—
0
0
502
4783
1.09
0.73
6.3
4.8
6.85
6.91
mmol/l
0.30
487
4554
26
345
0.75
0.73
1.5
1.3
—
—
—
0
0
247
2278
1.11
0.72
5.2
2.5
45.52
34.99
u/l
0.71
232
2122
247
2284
1.10
0.69
2.4
2.2
—
—
—
0
0
5
28
1.79
0.66
1.8
2.6
455.80
1214.75
u/ml
—
5
28
32
250
1.29
0.66
2.4
2.3
116.82
131.50
g/l
0.99
17
202
5
29
1.73
0.64
1.6
2.4
49.88
45.12
%
—
5
29
62
526
1.19
0.63
1.3
1.4
—
—
—
0
0
89
781
1.15
0.60
5.7
5.5
11.12
11.89
mmol/l
0.29
80
731
0
20
0.00
0.60
0.0
7.5
—
5.26
—
0
20
23
176
1.31
0.56
1.2
1.2
—
—
—
0
0
5
86
0.58
0.56
1.2
1.3
186.20
340.52
nmol/l
—
5
75
57
490
1.17
0.52
7.8
8.7
15.60
15.78
%
0.20
50
478
22
281
0.78
0.51
1.0
1.2
—
—
—
0
0
22
280
0.78
0.50
2.2
2.5
522.54
344.18
mg/l
0.34
13
92
31
252
1.24
0.50
2.7
2.2
352.04
85.82
ug/min
1.09
16
141
22
172
1.28
0.48
1.1
1.2
—
—
—
0
0
108
979
1.11
0.47
3.0
3.2
5.77
5.84
kpa
0.25
103
943
56
642
0.87
0.46
1.6
1.5
—
—
—
0
0
179
1914
0.92
0.43
2.7
2.5
7.21
4.62
e6/l
1.69
169
1734
10
70
1.43
0.41
1.2
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
4.01
—
0
6
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
28
336
0.83
0.40
3.7
3.9
1.80
1.48
mmol/l
0.60
28
327
0
18
0.00
0.40
0.0
1.2
—
1.68
—
0
13
22
270
0.81
0.39
1.8
3.3
0.77
0.82
nmol/l
0.25
15
211
78
863
0.90
0.39
2.5
3.3
201.18
286.52
ng/l
1.13
71
807
5
35
1.43
0.39
1.8
2.1
58.00
54.32
umol/l
—
5
30
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
84
762
1.11
0.38
6.0
7.1
—
—
—
0
0
105
965
1.10
0.38
3.0
3.2
1.93
1.88
mmol/l
0.04
86
817
5
37
1.35
0.37
2.6
3.4
—
—
—
0
0
15
191
0.78
0.37
1.1
1.1
—
795.71
—
0
7
82
898
0.91
0.35
1.9
1.8
—
—
—
0
0
166
1760
0.93
0.34
1.3
1.3
—
—
—
0
0
15
188
0.80
0.33
3.3
3.7
31.31
28.63
mg/l
—
10
139
17
137
1.24
0.32
1.5
2.1
3.20
41.24
iu/l
—
7
63
69
629
1.10
0.31
1.3
1.5
—
—
—
0
0
11
84
1.31
0.30
1.2
1.2
1.18
1.50
nmol/l
0.78
11
76
35
308
1.14
0.28
5.3
3.4
4.26
4.36
pmol/l
0.16
30
262
30
343
0.87
0.27
1.2
1.6
—
26.90
—
0
7
49
443
1.11
0.26
1.6
2.2
10.40
11.07
g/l
0.44
41
407
5
75
0.67
0.26
3.8
3.2
39.92
43.77
mg/l
—
5
57
16
192
0.83
0.25
1.2
1.2
569.06
554.91
mg/l
0.05
16
181
9
73
1.23
0.25
1.2
1.1
—
—
—
0
0
81
869
0.93
0.25
1.5
1.4
—
—
—
0
0
235
2266
1.05
0.24
2.8
3.2
0.77
0.43
e6/l
1.28
181
1699
17
143
1.19
0.23
1.2
1.1
—
—
—
0
0
7
94
0.74
0.22
1.7
1.2
—
—
nmol/l
—
0
0
562
5715
0.97
0.21
13.8
5.5
105.03
78.26
u/l
11.34
554
5264
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
6.91
—
0
7
8
104
0.77
0.21
1.1
1.2
—
—
—
0
0
5
43
1.16
0.21
2.6
3.3
—
—
—
0
0
316
3244
0.96
0.21
2.6
2.5
—
—
estimate
—
0
0
0
13
0.00
0.21
0.0
1.5
—
42.54
—
0
13
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
254
2465
1.04
0.20
2.7
2.3
64.33
61.84
u/l
0.18
227
2251
6
49
1.23
0.20
1.2
1.1
—
—
—
0
0
6
51
1.18
0.19
3.3
1.8
87.33
95.82
umol/l
—
6
51
7
58
1.21
0.18
1.0
1.3
—
—
—
0
0
105
1002
1.05
0.17
3.0
3.2
7.39
7.38
ph
0.26
54
592
264
2709
0.97
0.17
3.0
3.3
55.29
106.81
e6/l
0.79
208
2112
8
71
1.13
0.16
1.5
1.5
16.14
16.52
%
—
8
71
6
78
0.77
0.15
3.2
1.2
—
—
—
0
0
6
80
0.75
0.15
1.5
1.5
8.00
7.81
mmol/l
—
6
80
9
81
1.11
0.15
1.8
1.3
—
—
—
0
0
27
246
1.10
0.14
1.9
1.6
25.00
22.80
u/ml
—
5
44
8
98
0.82
0.13
1.0
1.0
—
—
—
0
0
134
1383
0.96
0.13
2.5
3.1
0.88
1.07
e6/l
0.42
61
777
9
106
0.85
0.13
1.4
1.2
0.51
17.68
nmol/l
—
9
100
86
827
1.04
0.12
3.0
2.7
4.20
4.40
kpa
0.48
81
789
10
116
0.86
0.12
1.0
1.2
—
—
—
0
0
312
3172
0.98
0.11
15.6
10.7
0.00
0.00
e9/l
2.15
241
2566
32
298
1.08
0.11
1.2
1.3
—
—
—
0
0
48
506
0.95
0.11
1.4
1.4
—
—
—
0
0
131
1279
1.03
0.09
2.5
3.2
2.95
1.75
e6/l
0.47
59
667
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
6
58
1.03
0.08
1.5
1.2
68.22
30.03
iu/l
—
6
47
5
63
0.79
0.08
1.0
1.4
—
—
—
0
0
8
75
1.07
0.07
1.4
1.2
—
—
—
0
0
8
76
1.05
0.07
1.3
1.8
309.63
279.43
mu/l
—
8
68
18
194
0.93
0.07
1.2
1.1
—
—
—
0
0
28
295
0.95
0.06
1.1
1.2
—
—
—
0
0
11
99
1.11
0.06
1.0
1.4
102.80
259.80
pmol/l
—
5
84
9
103
0.87
0.06
1.0
1.0
—
—
—
0
0
10
111
0.90
0.06
1.0
1.1
36.80
111.50
iu/ml
—
5
14
65
632
1.03
0.06
6.2
6.3
25.45
24.48
mmol/l
0.77
59
611
35
364
0.96
0.05
1.2
1.3
0.86
1.22
g/l
2.01
30
336
14
132
1.06
0.02
1.1
1.1
—
—
—
0
0
11
116
0.95
0.00
2.4
2.8
—
—
—
0
0
154
1542
1.00
0.00
1.5
1.6
2.17
1.40
mg/l
0.67
129
1206
20
195
1.03
0.00
1.4
1.4
302.67
307.82
ug/g
0.04
12
125
5
54
0.93
0.00
1.2
1.1
2.04
2.53
mmol/l
—
5
48
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
5
52
0.96
-0.00
2.4
2.8
—
—
—
0
0
8
81
0.99
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
28.8
—
0.24
—
0
5
5
51
0.98
-0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
371.56
—
0
5
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
201.80
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
345.00
—
0
5
5
51
0.98
-0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
2.07
—
0
6
9
99
0.91
-0.00
1.3
1.8
11.49
10.16
%
—
9
99
6
61
0.98
-0.00
1.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
100.57
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_SCLC – Small cell lung cancer

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).